Transgenic mice with global SIRT3 overexpression improved endothelial dysfunction and attenuated vascular oxidative stress, while SIRT3 depletion promoted endothelial dysfunction and exacerbate vascular hypertrophy in hypertension [28]. The gene discussed is SIRT3; the disease is cardiac hypertrophy.